Phase 4 cancer trials, also known as post-marketing or post-approval trials, occur after a treatment has been approved by regulatory agencies and is available for use in clinical practice. These trials aim to further evaluate the safety, effectiveness, and long-term outcomes of the treatment in larger and more diverse patient populations than those studied during earlier phases of clinical development.